These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11976718)

  • 21. The possible role of tumor necrosis factor (TNF) and its natural inhibitors, the soluble-TNF receptors, in autoimmune diseases.
    Aderka D; Engelmann H; Wysenbeek AJ; Levo Y
    Isr J Med Sci; 1992 Feb; 28(2):126-30. PubMed ID: 1313788
    [No Abstract]   [Full Text] [Related]  

  • 22. Nucleic acid recognizing Toll-like receptors and autoimmunity.
    von Landenberg P; Bauer S
    Curr Opin Immunol; 2007 Dec; 19(6):606-10. PubMed ID: 18060756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.
    Kyburz D; Rethage J; Seibl R; Lauener R; Gay RE; Carson DA; Gay S
    Arthritis Rheum; 2003 Mar; 48(3):642-50. PubMed ID: 12632416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technology evaluation: CpG-7909, Coley.
    Paul S
    Curr Opin Mol Ther; 2003 Oct; 5(5):553-9. PubMed ID: 14601526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of DNA-binding activity of blood serum in systemic lupus erythematosus, rheumatoid arthritis and crossing syndromes].
    Matveĭkov GP; Podgorodnichenko VK; Koshelev VK; Nazarov IuM
    Ter Arkh; 1976; 48(11):36-40. PubMed ID: 1021891
    [No Abstract]   [Full Text] [Related]  

  • 27. Now I know my CpGs.
    Krieg AM
    Trends Microbiol; 2001 Jun; 9(6):249-52. PubMed ID: 11390225
    [No Abstract]   [Full Text] [Related]  

  • 28. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CpG DNA stimulates autoreactive immature B cells in the bone marrow.
    Azulay-Debby H; Edry E; Melamed D
    Eur J Immunol; 2007 Jun; 37(6):1463-75. PubMed ID: 17474151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Henneken M; Dörner T; Burmester GR; Berek C
    Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. For whom the bug tolls.
    Goldberg J
    Trends Microbiol; 2001 Mar; 9(3):109. PubMed ID: 11239775
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.
    Babiuk S; Mookherjee N; Pontarollo R; Griebel P; van Drunen Littel-van den Hurk S; Hecker R; Babiuk L
    Immunology; 2004 Sep; 113(1):114-20. PubMed ID: 15312142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CpG motifs: the active ingredient in bacterial extracts?
    Krieg AM
    Nat Med; 2003 Jul; 9(7):831-5. PubMed ID: 12835699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing immunogenicity by CpG DNA.
    Jiang W; Pisetsky DS
    Curr Opin Mol Ther; 2003 Apr; 5(2):180-5. PubMed ID: 12772509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptor signaling in anti-cancer immunity.
    Okamoto M; Sato M
    J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?
    Binard A; Le Pottier L; Saraux A; Devauchelle-Pensec V; Pers JO; Youinou P
    J Autoimmun; 2008; 30(1-2):63-7. PubMed ID: 18155417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity's early-warning system.
    O'Neill LA
    Sci Am; 2005 Jan; 292(1):24-31. PubMed ID: 15724335
    [No Abstract]   [Full Text] [Related]  

  • 40. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.